Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Employment agrmnt
Quarterly results
Director comp.

MoonLake Immunotherapeutics Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 4 Chen Bihua (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Bought 58,839 shares @ $59.8973, valued at $3.5M
10/04/2023 4 Chen Bihua (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Bought 74,911 shares @ $57.37, valued at $4.3M
Bought 150,487 shares @ $57.252, valued at $8.6M
Bought 67,814 shares @ $57.3188, valued at $3.9M
10/03/2023 4 Sturge Simon (Director) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Converted 342,980 shares @ $0
Disposed/sold 342,980 shares @ $0
Converted 10,196 options to buy @ $0
10/03/2023 4 Bodenstedt Matthias (CFO) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Converted 62,972 shares @ $0
Disposed/sold 62,972 shares @ $0
Converted 1,872 options to buy @ $0
10/03/2023 4 Santos da Silva Jorge (CEO) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Converted 3,027,483 shares @ $0
Disposed/sold 3,027,483 shares @ $0
Converted 140,071 shares @ $0
Disposed/sold 140,071 shares @ $0
Converted 90,000 options to buy @ $0
Converted 4,164 options to buy @ $0
10/03/2023 4 Reich Kristian (Chief Scientific Officer) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Converted 2,527,477 shares @ $0
Disposed/sold 2,527,477 shares @ $0
Converted 41,981 shares @ $0
Disposed/sold 41,981 shares @ $0
Converted 75,136 options to buy @ $0
Converted 1,248 options to buy @ $0
07/05/2023 4 Chen Bihua (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Bought 800,000 shares @ $50, valued at $40M
06/28/2023 4 Chen Bihua (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Bought 1,481 shares @ $36.91, valued at $54.7k
Bought 3,755 shares @ $38.18, valued at $143.4k
Bought 10,593 shares @ $39.17, valued at $414.9k
Bought 38,623 shares @ $39.87, valued at $1.5M
Bought 50,642 shares @ $41.03, valued at $2.1M
Bought 61,042 shares @ $42.12, valued at $2.6M
Bought 66,087 shares @ $43.3, valued at $2.9M
Bought 31,558 shares @ $44.23, valued at $1.4M
Bought 10,946 shares @ $44.93, valued at $491.8k
Bought 37,783 shares @ $48.93, valued at $1.8M
Bought 59,787 shares @ $49.82, valued at $3M
06/12/2023 4 BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Granted 11,297 options to buy @ $29.18, valued at $329.6k
06/12/2023 4 Sturge Simon (Director) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Granted 11,297 options to buy @ $29.18, valued at $329.6k
06/12/2023 4 Xavier Ramnik (Director) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Granted 11,297 options to buy @ $29.18, valued at $329.6k
06/12/2023 4 Loy Spike (Director) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Granted 11,297 options to buy @ $29.18, valued at $329.6k
06/12/2023 4 Moukheibir Catherine (Director) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Granted 11,297 options to buy @ $29.18, valued at $329.6k
06/12/2023 4 Phillips Andrew John (Director) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Granted 11,297 options to buy @ $29.18, valued at $329.6k
03/22/2023 4 Chen Bihua (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Bought 446,881 shares @ $19.3639, valued at $8.7M
Bought 63,700 shares @ $20.4207, valued at $1.3M
Bought 78,008 shares @ $21.0836, valued at $1.6M
Bought 238,511 shares @ $21.7013, valued at $5.2M
05/05/2022 4 Sturge Simon (Director) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Granted 45,000 options to buy @ $12.25, valued at $551.3k
05/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/15/2022 3 BVF PARTNERS L P/IL (10% Owner) has filed a Form 3 on MoonLake Immunotherapeutics
04/15/2022 3 Reich Kristian (Chief Scientific Officer) has filed a Form 3 on MoonLake Immunotherapeutics
04/15/2022 3 Santos da Silva Jorge (CEO) has filed a Form 3 on MoonLake Immunotherapeutics
04/15/2022 3 Sturge Simon (Director) has filed a Form 3 on MoonLake Immunotherapeutics
04/15/2022 3 Phillips Andrew John (Director) has filed a Form 3 on MoonLake Immunotherapeutics
04/15/2022 3 Bodenstedt Matthias (CFO) has filed a Form 3 on MoonLake Immunotherapeutics
04/15/2022 3 Lassen Kara (Director) has filed a Form 3 on MoonLake Immunotherapeutics
04/15/2022 3 Xavier Ramnik (Director) has filed a Form 3 on MoonLake Immunotherapeutics
04/15/2022 3 Loy Spike (Director) has filed a Form 3 on MoonLake Immunotherapeutics
04/15/2022 3 Moukheibir Catherine (Director) has filed a Form 3 on MoonLake Immunotherapeutics
04/07/2022 4 Helix Holdings LLC (Former 10% Holder) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Converted 2,785,000 shares @ $0
Converted 2,785,000 options to buy @ $0
04/07/2022 4 Chen Bihua (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Converted 2,785,000 shares @ $0
Bought 2,850,000 shares @ $10, valued at $28.5M
Converted 2,785,000 options to buy @ $0
10/22/2020 4 Chen Bihua (CEO and Chairman) has filed a Form 4 on Helix Acquisition Corp
Txns: Bought 430,000 shares @ $10, valued at $4.3M
10/22/2020 4 Helix Holdings LLC (10% Owner) has filed a Form 4 on Helix Acquisition Corp
Txns: Bought 430,000 shares @ $10, valued at $4.3M
10/19/2020 3 Chen Bihua (CEO and Chairman) has filed a Form 3 on Helix Acquisition Corp
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy